Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Trung Quang Ngo
Observed names:
Trung Ngo,
Trung Q. Ngo
Institutions:
The Royal Melbourne Hospital,
University College London Hospitals NHS Foundation Trust,
Australian Cancer Research Foundation,
Peter MacCallum Cancer Centre
Observed institutions:
The Royal Melbourne Hospital,
Barwon Health,
University College London Hospitals NHS Foundation Trust,
Australian Cancer Research Foundation,
Peter MacCallum Cancer Centre,
Monash Medical Centre,
Monash Health
show all 7
ORCID:
0000-0001-9124-8981
Observed ORCID:
0000-0001-9124-8981
OpenAlex ID:
A5083462079
Next-generation sequencing RNA fusion panel for the diagnosis of haematological malignancies
2024
·
Trung Quang Ngo
, Anna Fong Na Goh
, et al.
·
Pathology
·
9
A comparison between erythrocytapheresis and venesection for the treatment of JAK2 ‐mutated polycythaemia
2023
·
Trung Q. Ngo
, Matthew W. Scott
, et al.
·
Internal Medicine Journal
·
6
Successful treatment of Rosai‐Dorfman disease in the era of targeted therapy
2025
·
Trung Quang Ngo
, Pranav Dorwal
, et al.
·
Internal Medicine Journal
·
2
Integrating novel therapeutic strategies in myeloproliferative neoplasms: Driving disease‐directed progress
2026
·
Trung Q. Ngo
, Maria Georgiou
, et al.
·
British Journal of Haematology
·
1
How could calreticulin-targeting therapies change the myelofibrosis transplant paradigm?
2026
·
Amy MacDonald
, Isaac Gannon
, et al.
·
Bone Marrow Transplantation
PDF
Prospective phase I study of nivolumab to promote graft‐versus‐tumour in relapsed or refractory haematological malignancy post allogeneic haematopoietic stem cell transplantation
2026
·
Trung Q. Ngo
, Eric Wong
, et al.
·
British Journal of Haematology
PDF
Show more works
View as search
Works count:
6
Citation count:
18
H-index:
2
I10-index:
Year
Topic
Type